

VP Watchlist
The VP Watchlist contains current coverage companies that deserve consideration for short term and long term portfolio additions.
Latest News

Merck (MRK) is setting its sights on a new frontier—your eyes. The pharmaceutical heavyweight is on the verge of acquiring Eyebiotech, an ophthalmology biotech upstart, in a deal valued at a crisp&...
Read More
Eupraxia Pharmaceuticals Inc. (NASDAQ: EPRX, TSX: EPRX) has taken a significant step in its quest to address one of gastroenterology’s most stubborn challenges: eosinophilic esophagitis (E...
Read More
Serina Therapeutics (NYSE: SER) is positioning itself at the forefront of a new era in drug development, as highlighted in a recent corporate video titled "Rethinking Drug Development: Faster, Sma...
Read MoreVista Research

Blog & Newsletters
Exclusive daily market recaps & stories, weekly market views, and macroeconomic and investment newsletters help investors to stay current with real-time market coverage that is sent FREE directly to all that are in the Vista Network.
Learn More
Interviews
"Vista’s “Interviews Page” provides consolidated access to our sister organization Tribe Public’s Presentation and Q&A Event Webinar Series & other exciting interviews from other organizations that we would like to highlight from around the world."
Learn More